eNauka - pregled
Pregled prema Autor Stamatovic, Ljiljana
Prikaz rezultata 1 do 20 od 23
sledeće >
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2000 | Addition of medroxyprogesterone-acetate (MPA) to interferon-alpha (IFN) vinblastine (VLB) combination in advanced renal-cell carcinoma (RCC) - is there any impact on quality of life (QoL)? | Radosavljevic, Davorin Z; Jelic, Svetislav B; Babovic, Nada Lj; Popov, Ivan P; Kreacic, Miroslav; Stamatovic, Ljiljana; Nikolic-Tomasevic, Zorica I   ; Kezic, Iva | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2000 | Cisplatin dose intensity in poor risk germ cell tumors. | Babovic, Nada Lj; Jelic, Svetislav B; Stamatovic, Ljiljana | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2014 | Delays in diagnosis and treatment of breast cancer: a multinational analysis | Jassem, Jacek; Ozmen, Vahit; Bacanu, Florin; Drobniene, Monika; Eglitis, Janis; Lakshmaiah, Kuntegowdanahalli C; Kahan, Zsuzsanna; Mardiak, Jozef; Pienkowski, Tadeusz; Semiglazova, Tatiana;
Stamatovic, Ljiljana; Timcheva, Constanta; Vasovic, Suzana; Vrbanec, Damir; Zaborek, Piotr;
| Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2000 | Docetaxel-mitomycin-vinblastine combination chemotherapy in patients with anthracycline-resistant advanced breast cancer (ABC): An interim report. | Stamatovic, Ljiljana; Jelic, Svetislav B; Susnjar, Snezana V ; Vasovic, Suzana | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2010 | EVALUATION OF PROGNOSTIC VALUE OF HER2 AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) EXPRESSION FOR PREDICTING EARLY FAILURE IN PATIENTS WITH OPERABLE BREAST CANCER | Vasovic, Suzana; Stamatovic, Ljiljana; Tomasevic, Zoran M; Karaferic, Andjela; Pavlovic, L; Karadzic, Katarina; Jovanic, Irena P | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2012 | Factors influencing time to seeking medical advice and start of treatment in breast cancer (BC) patients - an International survey | Jassem, Jacek; Ozmen, Vahit; Bacanu, Florin; Drobniene, Monika; Eglitis, Janis; Kahan, Zsuzsanna; Lakshmaiah, Kuntegowdanahalli C; Mardiak, Jozef; Pienkowski, Tadeusz; Semiglazova, Tatiana;
Stamatovic, Ljiljana; Timcheva, Constanta; Vasovic, Suzana; Vrbanec, Damir; Zaborek, Piotr;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2014 | Factors Influencing Time to Seeking Medical Advice and Treatment Onset in Breast Cancer Patients in Serbia | Stamatovic, Ljiljana; Mamula-Masic, SD; Vukotic, Djordje; Kovac, Zeljko; Mihailovic, Z; Zdravkovic, K; Petkovic, Danijela; Bagi, Teodora; Milic, Natasa M | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2025 | Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study | O'Shaughnessy, Joyce; ...; Cvetanovic, Ana S; ...; Stamatovic, Ljiljana | Naučni članak | 22M22 - Međunarodni časopis kategorije M22 |
| 2003 | Negative CEA values in metastatic colorectal carcinoma and the likelihood of complete chemotherapy response | Tomasevic, Zorica I ; Jelic, Svetislav B; Nikolic, L; Filipovic, I; Stamatovic, Ljiljana; Radosavljevic, Davorin Z | Article | 22M22 |
| 2021 | Original Research Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study | O'Shaughnessy, Joyce; ...; Cvetanovic, Ana S; ...; Stamatovic, Ljiljana | Article | 21aM21a |
| 2000 | Paclitaxel-cisplatin as first line chemotherapy for undifferentiated carcinoma of the nasopharynx (UCNT): A preliminary report. | Jelic, Svetislav B; Babovic, Nada Lj; Stamatovic, Ljiljana; Vucicevic, Slavko S; Pendjer, Ivica P; Radulovic, Sinisa S | Conference Paper | Mp. category will be shown later |
| 2020 | Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study | O'Shaughnessy, Joyce; ...; Cvetanovic, Ana S; ...; Stamatovic, Ljiljana | Conference Paper | Mp. category will be shown later |
| 2020 | Patient (pt) preference for the pertuzumab-trastuzumab fixed-dose combination for subcutaneous use (PH FDC SC) in HER2-positive early breast cancer (EBC): Primary analysis of the open-label, randomised crossover PHranceSCa study | O'Shaughnessy, Joyce; ...; Cvetanovic, Ana; ...; Stamatovic, Ljiljana | Conference Paper | Mp. category will be shown later |
| 2012 | Patient-related factors influencing time between first signs of breast cancer (BC) and appointment for medical visit (AMV): An international survey | Jassem, Jacek; Bacanu, Florin; Eglitis, Janis; Mardiak, Jozef; Pienkowski, Tadeusz; Kahan, Zsuzsanna; Ozmen, Vahit; Drobniene, Monika; Vrbanec, Damir; Semiglazova, Tatyana;
Stamatovic, Ljiljana; Timcheva, Constanta; Vasovic, Suzana; Zaborek, Piotr;
| Conference Paper | Mp. category will be shown later |
| 2019 | Patient-reported outcomes (PROs) from KATHERINE: A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer. | Schneeweiss, Andreas; ...; Stamatovic, Ljiljana; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |
| 2012 | Postmenopausal Early Breast Cancer Patients - the Relevance of Quantitative ER Values and Follow-up Periods | Markicevic, Milan A; Vujasinovic, Tijana; Abu, Rabi Zaki ; Neskovic-Konstantinovic, Zora B; Stamatovic, Ljiljana; Nikolic-Vukosavljevic, Dragica | Conference Paper | Mp. category will be shown later |
| 2015 | Prevention of Chemotherapy-Induced Nausea and Vomiting (Cinv) with Nepa, the First Oral Combination Antiemetic, in Patients with Gynecological Cancers Receiving Platinum-Based Chemotherapy | Bosnjak, Snezana M; Stamatovic, Ljiljana; Jordan, Karin; Rizzi, Giada | Conference Paper | Mp. category will be shown later |
| 2007 | Relationship of steroid receptor (SR) status and response to fluorouracil, doxorubicine and cyclophosphamide (FAC) primary systemic therapy (PST) in locally advanced breast cancer (LABC) patients | Susnjar, Snezana V ; Gavrilovic, Dusica; Neskovic-Konstantinovic, Zora B; Stamatovic, Ljiljana; Ursulovic, Tamara B | Conference Paper | Mp. category will be shown later |
| 2002 | Salvage capecitabine-leucovorine-vinorelbine combination chemotherapy in both anthracycline and taxane resistant metastatic breast cancer | Stamatovic, Ljiljana; Jelic, Svetislav B; Susnjar, Snezana V ; Vasovic, Suzana; Nikolic-Tomasevic, Zorica I ; Neskovic-Konstantinovic, Zora B | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2025 | Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer | Geyer, Jr Charles E; ...; Stamatovic, Ljiljana; ...; (broj, koautora 35) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |